A variety of statistical models are now available for assessing survival. In order to select the appropriate model for a particular analysis, it is important to consider the time-course of the hazard under study. For example, to model the risk of developing cancer in humans or in experimental animals exposed to a carcinogen, one must select a hazard function (such as the Weibul or Gompertz) that increases over time, to match the progressive risk that is observed in these populations (Cook et al., 1969; Pike 1966) . A progressive increase in risk is also required to model deaths from all causes among adult humans, since likelihood of death increases with age in this population.
An altogether different model is needed, however, when studying survival with respect to a specific histologic type of tumour that has been treated by a potentially curative therapy. In order to focus on the tumour under study, distinction must be made between deaths due to this tumour and deaths due to unrelated causes. If reliable follow-up data is available, one can consider patients that died of other causes to be withdrawn alive at the time of death (Cutler & Axtell, 1969) . Since risk of death from the tumour under study may eventually decline, as ascending hazard function would not give a good fit to observed survival ( Figure 1) . Furthermore, those patients that are cured are not at risk of death from their tumour, and thus a successful model must allow for a risk-free portion (or cured fraction) within the population.
This reasoning suggests that a model of tumour-specific survival can be constructed by combining a cured fraction with a distribution of time-to-death among uncured patients. One alternative is to approximate specific biologic pathways within the malignant process, using selected mathematical functions. Though this approach has become popular with the advent of sophisticated computer technology, it may demand numerous simplifying assumptions and the resulting conclusions, though sometimes useful, may apply only to the malignancy for which the model was derived (Birkhead, 1985; Gregory et al., 1991 (Boag, 1949) . The (Mould & Boag, 1975; Mould et al., 1976; Rutqvist et al., 1984; Gamel et al., 1990 (Cox, 1972 Recently, a refinement of the original Boag model has been developed that allows C and M to be expressed as linear regressions on prognostic covariates (Gamel et al., 1990) of the remaining 2,073 patients, the following covariates were known: sex of the patient, age of the patient at the time of initial treatment, degree of differentiation of the primary tumour, node status at the time of treatment, duration of followup, and status at last followup.
Host factors are shown in Table I and tumour factors are shown in Table II (Broders, 1926; Thomson, 1939) and assigned the category of well, moderately, or poorly differentiated.
In Table III , primary sites for the data base are given. Approximately one-third of the cases are carcinoma of the larnyx and a further third are carcinoma of the pharynx. One-fifth of cases has a carcinoma of the oral cavity. Tumours of the nose and sinuses, post-nasal space, ear, salivary glands, etc. form the remaining cases.
In Table IV the various forms of treatment are indicated. In the UK, the general policy of the Head and Neck Cancer Units is to treat by primary radiotherapy wherever possible, with the option of salvage surgery. In the present data base, 51% of all new patients were treated initially by radiotherapy with curative intent, but approximately one-third of these patients required salvage surgery. Of all patients, 29% were The univariate and multivariate lognormal models have been described in detail elsewhere (Boag, 1949; Gamel et al., 1990) . For univariate analysis, each covariate was entered into both components of the lognormal model (i.e., cured fraction and mean log survival time). For multivariate analysis, all covariates were included in both components of the lognormal model. In order to demonstrate the relative prognostic value of all covariates, no step-down procedure was performed.
To determine the interaction of covariates, standard linear regression analysis was used. In order to assess the possible interaction of the studied covariates with therapeutic decisions, cross-correlation with type of therapy was also examined. For this analysis, surgery was coded as 2 if definitive resection was attempted and as 1 (Norris, 1963) . Stell noted that neck node status completely overshadows other prognostic factors in laryngeal carcinoma and that patients with nodal involvement were likely to have high T stage and poorly differentiated tumours (Stell, 1990b As can be seen in Table V , histologic type and age are also important predictors for SCHN. Unlike nodal status, however, these two covariates are asymmetric predictors-histologic type is significantly associated only with cured fraction, while age is significantly associated only with median survival time.
Kleinsasser in 1961 noted that undifferentiated carcinoma of the larnyx has a poor prognosis and this association was attributed to the fact that these tumours metastasise early. Stell, however, (Stell, 1990b) found histological differentiation to be nonsignificant regarding survival after allowing for confounding variables. Our finding that histologic type is associated with cured fraction rather than survival time may explain this apparent contradiction.
The existence of highly asymmetric predictors such as age and histologic type suggest an important conclusion-that those mechanisms which govern the likelihood of metastasis are distinct from those that govern survival time for uncured patients. Specifically, poorly differentiated cells within SCHN are apparently more likely to metastasise than well differentiated cells, but these metastatic foci do not seem to grow more quickly than their better differentiated counterparts. On the other hand, old age has a highly significant interaction with survival time but not with cured fraction, suggesting the possibility that rate of metastatic proliferation, rather than the occurrence of metastasis, increases substantially with increasing age at diagnosis. A second possibility is age-associated delay in diagnosis; this association appears unlikely, however, since the multivariate model contains a covariate (node status) that characterises tumour stage at diagnosis and thus should control for delay in diagnosis. A third possibility is that older patients succumb at a relatively smaller tumour burden than younger patients. It should be noted that age also demonstrated a strong and asymmetric association with survival time for patients with melanoma of the skin and of the eye (Gamel et al., in preparation a,b) .
For many years it has been assumed that prognosis from SCHN is better in younger than older patients (Lauerma, 1967) . This assumption has been borne out by careful statistical investigations (Huygen et al., 1980; Katz, 1983) . On the other hand, with use of the Cox regression model Stell found that age was not a significant predictor of survival when allowance was made for those patients that were untreated or died of intercurrent disease or of a second primary tumour (Stell, 1990a) . This disparity may result from a difference in statistical methods.
Before attributing biologic significance to these observations, however, it is important to consider the interactions among covariates shown in Table VI . These interactions imply that patients with nodal involvement are less likely to have radiation therapy and more likely to have poorly differentiated tumours than those without nodal involvement. Old patients are also less likely than young patients to have surgery and less likely to have nodal involvement. Some of these associations are of marginal biologic significance-e.g., only 0.64% of the variation in age can be explained by node status.
Nevertheless, because of the large number of patients included in this study, there may be sufficient statistical significance to impact patient survival. Thus the interaction of covariates with therapy and with each other can significantly affect their prognostic value within the lognormal model.
Because of these limitations, are because of the limitations that arise from the complexities of multivariate survival analysis itself, no firm conclusions can be drawn from the results shown in Table V . Nevertheless, these findings raise important biologic questions that warrant further investigation, both in the clinic and in the laboratory.
